Table 2 General characteristics of cannabis and cannabinoid publications
From: A bibliometric analysis of the cannabis and cannabinoid research literature
Publication volume | |||
Number of total publications (n = 29 802) | |||
Number of open access publications (n = 10 214) | (% of publications) | 34.27% | |
Document type (# of publications) | Article (n = 26 296) | 88.24% | |
Review (n = 3506) | 11.76% | ||
Source titles (journals) across all publications (n = 5474) | |||
Unique authors across all publications (n = 65 109) | |||
Subject area of publication (10 highest) | |||
(# of publications) | Medicine (n = 17 124) | (% of publications) | 57.46% |
Pharmacology, Toxicology and Pharmaceutics (n = 8604) | 28.87% | ||
Biochemistry, Genetics and Molecular Biology (n = 5827) | 19.55% | ||
Neuroscience (n = 4266) | 14.31% | ||
Psychology (n = 2542) | 8.53% | ||
Social Sciences (n = 2188) | 7.34% | ||
Chemistry (n = 2167) | 7.27% | ||
Agricultural and Biological Sciences (n = 1578) | 5.30% | ||
Environmental Science (n = 864) | 2.90% | ||
Nursing (n = 676) | 2.27% | ||
Language of publication (10 highest) | |||
(# of publications) | English (n = 27 715) | (% of publications) | 93.00% |
German (n = 658) | 2.21% | ||
French (n = 490) | 1.64% | ||
Spanish (n = 362) | 1.22% | ||
Chinese (n = 133) | 0.45% | ||
Dutch (n = 91) | 0.31% | ||
Italian (n = 78) | 0.26% | ||
Portuguese (n = 76) | 0.26% | ||
Japanese (n = 63) | 0.21% | ||
Norwegian (n = 52) | 0.17% | ||
Country of publication (10 highest) | |||
(# of publications) | USA (n = 12 420) | (% of publications) | 41.68% |
UK (n = 2236) | 7.50% | ||
Canada (n = 2062) | 6.92% | ||
Germany (n = 1694) | 5.68% | ||
Italy (n = 1663) | 5.58% | ||
Spain (n = 1384) | 4.64% | ||
Australia (n = 1325) | 4.45% | ||
France (n = 1030) | 3.46% | ||
Netherlands (n = 795) | 2.67% | ||
China (n = 755) | 2.53% | ||
Institutional affiliation (10 highest) | |||
(# of publications) | University of Toronto (n = 455) | (% of publications) | 1.53% |
King’s College London (n = 428) | 1.44% | ||
National Institutes of Health (n = 426) | 1.43% | ||
Virginia Commonwealth University (n = 386) | 1.30% | ||
Universidad Complutense de Madrid (n = 372) | 1.25% | ||
University of Washington, Seattle (n = 354) | 1.19% | ||
National Institute on Drug Abuse (n = 348) | 1.17% | ||
Harvard Medical School (n = 341) | 1.14% | ||
Inserm (n = 335) | 1.12% | ||
Universidade de Sao Paulo (n = 328) | 1.10% | ||
Funding sponsor (10 highest) | |||
(# of publications) | National Institutes of Health (USA) (n = 5848) | (% of publications) | 19.62% |
Department of Health and Human Services (USA) (n = 5778) | 19.39% | ||
National Institute on Drug Abuse (USA) (n = 4371) | 14.67% | ||
National Institute on Alcohol Abuse and Alcoholism (USA) (n = 1007) | 3.38% | ||
National Institute of Mental Health (USA) (n = 647) | 2.17% | ||
European Commission (n = 434) | 1.46% | ||
Government of Canada (n = 394) | 1.32% | ||
National Cancer Institute (USA) (n = 317) | 1.06% | ||
Canadian Institutes of Health Research (n = 314) | 1.05% | ||
UK Research and Innovation (n = 299) | 1.00% | ||